V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody
260€ (50 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx241339
tested applications
ELISA, IHC
Description
VTCN1 Antibody is a Rabbit Polyclonal against VTCN1.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | ELISA: 1/2000 - 1/5000, IHC: 1/25 - 1/100. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Antigen Affinity Chromatography. |
| Size 1 | 50 µl |
| Size 2 | 100 µl |
| Form | Liquid |
| Tested Applications | ELISA, IHC |
| Buffer | PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q7Z7D3 |
| Gene ID | 79679 |
| Background | Antibody anti-VTCN1 |
| Status | RUO |
Descripción
Related Products
Human VTCN1 (V-set domain-containing T-cell activation inhibitor 1) ELISA Kit
Ver Producto
VTCN1 antibody
Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.
Ver Producto